Blog
RSS FeedPosted by Michael Wonder on 18 Mar 2021
Investment in innovative medicines needed to safeguard Australia’s long-term prosperity
17 March 2021 - Medicines Australia has lodged its 2021-22 Pre-Budget Submission with The Treasury which outlines several recommendations to ...
Posted by Michael Wonder on 06 May 2020
Medicines Australia joins forces with 15 health care organisations to highlight continuity of care
6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...
Posted by Michael Wonder on 26 Apr 2020
Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies
26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...
Posted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...
Posted by Michael Wonder on 04 Dec 2019
'Cannot be trusted ... causing harm': top medical journal takes on big pharma
4 December 2019 - A leading medical journal is launching a global campaign to separate medicine from big pharma, linking ...
Posted by Michael Wonder on 22 Oct 2019
Can we stop the medicine arms race?
22 October 2019 - Patients at risk of “exploitative manipulation” from medicines lobbyists if PBS politicisation continues, doctor tells parliament ...
Posted by Michael Wonder on 22 Jan 2019
Access, value and investment: making the right choices for a healthy Australia
22 January 2019 - Medicines Australia has today lodged its submission to the 2019-2020 Federal Budget. ...
Posted by Michael Wonder on 16 Jan 2019
Pharmaceutical companies spent $34m on patient advocacy groups, research finds
16 January 2019 - Money often spent while companies had drugs ‘under review for public reimbursement’ through PBS. ...
Posted by Michael Wonder on 17 Dec 2018
Medicines Australia welcomes the Government’s recognition of the importance of medicines
17 December 2018 - Medicines Australia welcomes today’s Mid-Year Economic and Fiscal Outlook, announced by Treasurer the Hon. Josh Frydenberg ...
Posted by Michael Wonder on 19 Sep 2018
My Health Record: big pharma can apply to access data
18 September 2018 - ‘Each application would be assessed on its own merits,’ senators told. ...
Posted by Michael Wonder on 17 Sep 2018
Pharma companies avoid estimated $215m a year in local tax: Oxfam
18 September 2018 - Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in ...
Posted by Michael Wonder on 29 Jan 2018
Medicines Australia welcomes LSDP review outcomes
28 January 2018 - Medicines Australia welcomes the Government’s announcement of an outcome from the post-market review of the Life ...
Posted by Michael Wonder on 13 Jul 2017
AusBiotech welcomes industry nominee to PBAC
13 July 2017 - AusBiotech has today welcomed the appointment of industry nominee Michelle Burke to the PBAC, who is ...
Posted by Michael Wonder on 13 Jul 2017
PBAC announces appointment of industry expert to Committee
13 July 2017 - Medicines Australia is pleased to welcome the appointment of Michelle Burke to the PBAC. ...
Posted by Michael Wonder on 09 May 2017
Strategic Agreement between the Innovative pharmaceutical industry and government delivers certainty for industry, savings to taxpayers and benefits to patients
9 May 2017 - Medicines Australia has signed a strategic agreement with the Australian Government that will support ongoing access ...